|
India Rises to 8th in WHO VigiBase Contributions Under WHO PIDM
India moves to 8th position in 2025 from 123rd in 2014 in contributions to WHO’s VigiBase under the WHO Programme for International Drug Monitoring (WHO PIDM). The improvement is attributed to the Pharmacovigilance Programme of India (PvPI), which analyses drug-related adverse events and sends recommendations to CDSCO for regulatory actions.
WHO VigiBase Contributions under WHO PIDM:
| Dimension | Key Details |
|---|---|
| Current trigger | India ranks 8th in 2025 in contributions to WHO’s pharmacovigilance database (VigiBase) under WHO PIDM; rank is 123rd in 2014. |
| Attribution | Improvement in ranking is attributed to the Pharmacovigilance Programme of India (PvPI). |
| Pharmacovigilance Programme of India (PvPI) | Launched in 2010; Government of India’s flagship drug safety monitoring programme. |
| PvPI: functions | Analyses drug-related adverse events; sends recommendations to CDSCO for taking appropriate regulatory actions. |
| WHO Programme for International Drug Monitoring (WHO PIDM) | Established in 1968; provides for putting medicines and vaccine safety at the heart of global healthcare. |
| VigiBase | Comprises WHO global database of adverse event reports for medicines and vaccines. |